InvestorsHub Logo
Followers 100
Posts 42096
Boards Moderated 2
Alias Born 01/17/2006

Re: None

Monday, 03/13/2006 11:14:35 AM

Monday, March 13, 2006 11:14:35 AM

Post# of 3413
Amex:TTG Tutogen Medical, Inc. Contacted by Zimmer Holdings, Inc. to Discuss Potential Strategic...

ALACHUA, Fla., March 13 /PRNewswire-FirstCall/ -- Tutogen Medical, Inc.
(Amex: TTG), a leading manufacturer of sterile biological implant products
made from human (allograft) and animal (xenograft) tissue, today announced
that Mr. Guy L. Mayer, Chief Executive Officer of Tutogen, has been contacted
by representatives of Zimmer Holdings, Inc. to enter into discussions on a
range of potential strategic transactions, which could possibly include
further investment by Zimmer in securities of Tutogen Medical or the
acquisition by Zimmer of some or all of the outstanding common stock of
Tutogen.

Zimmer Holdings, Inc. filed Schedule 13 D/A on Friday, March 10, 2006
expressing its intention to initiate discussions with Tutogen Medical, Inc.

Guy L. Mayer, president and CEO of Tutogen Medical, said, "We have made a
great deal of progress in the past year in positioning the Company for
improved performance. We believe this approach by Zimmer is indicative of
that progress. We look forward to considering any and all strategic options
that will help us to expand the reach of our products worldwide and that will
appropriately enhance value for our loyal shareholders."

About Tutogen Medical, Inc.
Tutogen Medical, Inc. manufactures sterile biological implant products
made from human (allograft) and animal (xenograft) tissue. Tutogen utilizes
its Tutoplast Process(R) of tissue preservation and viral inactivation to
manufacture and deliver sterile bio-implants used in spinal/trauma, urology,
dental, ophthalmology, and general surgery procedures. The Company's
Tutoplast(R) products are sold and distributed worldwide by Zimmer Spine and
Zimmer Dental, subsidiaries of Zimmer Holdings, Inc. the Mentor Corporation,
IOP, Inc. and through independent distributors and subsidiaries in the U.S.
and other international markets. For more information, visit the Company's
Web site at http://www.tutogen.com .

Contacts:

Bob Johnston
Chief Financial Officer Lytham Partners, LLC
Tutogen Medical, Inc. Institutional: Joe Diaz
386-462-0402 ext. 109 Retail: Joe Dorame
bjohnston@tutogen.com 602-889-9700

SOURCE Tutogen Medical, Inc.

Bob Johnston, Chief Financial Officer of Tutogen Medical, Inc.,
+1-386-462-0402, ext. 109, bjohnston@tutogen.com; or Institutional, Joe Diaz,
or Retail, Joe Dorame, both of Lytham Partners, LLC, +1-602-889-9700, for
Tutogen Medical, Inc.
13Mar06 14:51 GMT
Symbols:
us;TTG
Source PRN PR Newswire
Categories:
NWI/BIO NWI/HEA NWI/MTC MST/I/BTC MST/I/DRG MST/I/HEA MST/I/MDV MST/L/EN
MST/R/US/FL TGT/PRX


Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.